Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  NY-ESO-1(157-165) peptide-pulsed autologous dendritic cell vaccine
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients with Locally Advanced or Metastatic Malignancies
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 16 and over
Trial IDs: 13-001624, NCI-2014-00221, 1311-1278, 208.13.0-h, CA184-346, NCT02070406
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients with Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
Status: Not yet active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 16 and over
Trial IDs: 15-001433, NCI-2016-00201, Ribas NYESO + Nivolumab Cancer (NYN), NCT02775292
Start Over